Table 4.
Coefficient of Variance for Prostate Cancer Arrays.
Shown is the antigen-autoantibody reactivity with the CV from spot-to-spot (within an array). Also shown are the CV values for the antigen-autoantibody reactivity in well-to-well (in duplicate arrays). At the bottom of the table, the mean CV value for all antigens is shown.
| Array 1 | Array 2 | Array 1 and Array 2 | |
|---|---|---|---|
| Spot # | Spot to Spot CV | Spot to Spot CV | Well to Well CV |
| 1 Control | 12% | 16% | 9% |
| 2 Control | 18% | 20% | 17% |
| 3 Control | 11% | 17% | 13% |
| 4 Control | 13% | 18% | 14% |
| 5 PARK7 | 11% | 8% | 12% |
| 6 CCNA2 | 13% | 13% | 18% |
| 7 ACID2 | 13% | 17% | 19% |
| 8 CALD1 | 14% | 16% | 17% |
| 9 CHD-3 | 19% | 14% | 16% |
| 10 DBN1 | 18% | 19% | 21% |
| 11 GAPDHS | 18% | 17% | 17% |
| 12 HSF4 | 17% | 16% | 17% |
| 13 KLK3 | 15% | 16% | 18% |
| 14 NFAT1 | 13% | 16% | 16% |
| 15 PEX10 | 14% | 14% | 19% |
| 16 SOS1 | 18% | 20% | 24% |
| 17 STAT2 | 14% | 14% | 21% |
| 18 STX6 | 17% | 26% | 27% |
| 19 TARDBP | 14% | 14% | 11% |
| 20 TLN1 | 10% | 9% | 12% |
| 21 AR | 20% | 16% | 21% |
| 22 b-Tubulin | 8% | 12% | 15% |
| 23 CASP8 | 12% | 12% | 18% |
| 24 Cyclin D1 | 10% | 15% | 21% |
| 25 HSPA1A/B | 14% | 14% | 20% |
| 26 p53 | 12% | 18% | 19% |
| 27 p73 | 14% | 13% | 19% |
| 28 LEDGF/PSIP1 |
16% | 15% | 22% |
| 29 PTEN | 18% | 20% | 16% |
| 30 PXN | 14% | 17% | 19% |
| 31 TOP1 | 9% | 10% | 16% |
| Averages | 14% | 16% | 17% |